Structures by: Tejchman W.
Total: 5
4-Methyl-1-(4-methoxyphenyl)-6-phenylpyrimidine-2(1<i>H</i>)-selenone
C18H16N2OSe
Acta Crystallographica Section C (2020) 76, 4 359-366
a=12.7330(3)Å b=8.9500(2)Å c=14.1399(5)Å
α=90° β=101.862(2)° γ=90°
4-Methyl-1-(3-methoxyphenyl)-6-phenylpyrimidine-2(1<i>H</i>)-selenone
C18H16N2OSe
Acta Crystallographica Section C (2020) 76, 4 359-366
a=9.4670(6)Å b=10.3070(7)Å c=16.6150(9)Å
α=90° β=106.887(4)° γ=90°
4-Methyl-1-(2-methoxyphenyl)-6-phenylpyrimidine-2(1<i>H</i>)-selenone
C18H16N2OSe
Acta Crystallographica Section C (2020) 76, 4 359-366
a=14.8080(2)Å b=15.6970(2)Å c=14.9770(2)Å
α=90° β=114.4820(10)° γ=90°
(<i>Z</i>)-4-(4-Chlorobenzylidene)-2-(4-methylpiperazin-1-yl)-1<i>H</i>-imidazol-5(4<i>H</i>)-one
C15H17ClN4O
Acta Crystallographica Section C (2018) 74, 11
a=9.1010(6)Å b=13.1770(7)Å c=13.3280(7)Å
α=70.334(4)° β=89.469(3)° γ=86.582(4)°
4-[4-(4-Chlorobenzylidene)-5-oxo-4,5-dihydro-1<i>H</i>-imidazol-2-yl]-1-methylpiperazin-1-ium 3-{5-[4-(diethylamino)benzylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl}propionate
C15H18ClN4O,C17H19N2O3S2
Acta Crystallographica Section C (2018) 74, 11
a=10.937(5)Å b=11.384(5)Å c=14.488(5)Å
α=77.450(5)° β=81.731(5)° γ=68.704(5)°